Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Am Vet Med Assoc. 2004 Oct 15;225(8):1237-41.

Use of low molecular weight heparin in cats: 57 cases (1999-2003).

Author information

  • 1Department of Clinical Sciences, School of Veterinary Medicine, Tufts University, North Grafton, MA 01536, USA.

Abstract

OBJECTIVE:

To determine duration of administration, complications, and frequency of aortic thromboembolism associated with administration of low molecular weight heparin (dalteparin) in cats.

DESIGN:

Retrospective study.

ANIMALS:

57 cats treated with dalteparin

PROCEDURE:

Data were recorded from the medical records of cats treated with dalteparin, and owners were contacted by telephone for information regarding ease of administration and possible adverse effects.

RESULTS:

Dalteparin was easily administered by owners. Median dose was 99 U/kg (45 U/lb) once or twice daily. Bleeding complications were infrequent. Of 43 cats with cardiomyopathy that received owner-administered dalteparin for a median follow-up time of 172 days, 8 cats developed documented or possible arterial thromboembolism.

CONCLUSIONS AND CLINICAL RELEVANCE:

Dalteparin was easily administered by owners and was well tolerated by cats. Whether dalteparin administration can reduce the frequency or severity of arterial thromboembolism is not yet known.

PMID:
15521447
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk